TIGERMED (03347) Announces February 2026 Monthly Return on Movements in Securities

Bulletin Express

Mar 05

Hangzhou Tigermed Consulting Co., Ltd. disclosed its February 2026 monthly return on securities, confirming that the total authorized share capital remained at RMB 861.03 million. The balance of authorized A shares stood at 737.90 million shares, and H shares remained at 123.12 million shares. Par values were unchanged at RMB 1.00 each.

The number of issued A shares (excluding treasury shares) stayed at 732.02 million, with 5.88 million shares held in treasury. The total issued H shares remained at 123.12 million with no treasury shares. The public float requirement for the H shares was reported as fully compliant. The company also noted that a cumulative 5.88 million A shares remain in treasury following various repurchases from May 2024 to February 2025 and a cancellation of 3.92 million treasury shares on 29 May 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1164352498"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164352498\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164352498?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 17:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164352498","market":"us","top_or_hot":-1,"title":"TIGERMED (03347) Announces February 2026 Monthly Return on Movements in Securities","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. disclosed its February 2026 monthly return on securities, confirming that the total authorized share capital remained at RMB 861.03 million. The balance of authorized A shares stood at 737.90 million shares, and H shares remained at 123.12 million shares. Par values were unchanged at RMB 1.00 each.</p>\n<p>The number of issued A shares (excluding treasury shares) stayed at 732.02 million, with 5.88 million shares held in treasury. The total issued H shares remained at 123.12 million with no treasury shares. The public float requirement for the H shares was reported as fully compliant. The company also noted that a cumulative 5.88 million A shares remain in treasury following various repurchases from May 2024 to February 2025 and a cancellation of 3.92 million treasury shares on 29 May 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TIGERMED (03347) Announces February 2026 Monthly Return on Movements in Securities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTIGERMED (03347) Announces February 2026 Monthly Return on Movements in Securities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-05 17:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. disclosed its February 2026 monthly return on securities, confirming that the total authorized share capital remained at RMB 861.03 million. The balance of authorized A shares stood at 737.90 million shares, and H shares remained at 123.12 million shares. Par values were unchanged at RMB 1.00 each.</p>\n<p>The number of issued A shares (excluding treasury shares) stayed at 732.02 million, with 5.88 million shares held in treasury. The total issued H shares remained at 123.12 million with no treasury shares. The public float requirement for the H shares was reported as fully compliant. The company also noted that a cumulative 5.88 million A shares remain in treasury following various repurchases from May 2024 to February 2025 and a cancellation of 3.92 million treasury shares on 29 May 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1164352498","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164352498","pubTimestamp":1772703234,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. disclosed its February 2026 monthly return on securities, confirming that the total authorized share capital remained at RMB 861.03 million. The balance of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药(03347)公布2026年2月证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. disclosed its February 2026 monthly return on securities, confirming that the total authorized share capital remained at RMB 861.03 million. The balance of authorized A shares stood at 737.90 million shares, and H shares remained at 123.12 million shares. Par values were unchanged at RMB 1.00 each.\nThe number of issued A shares (excluding treasury shares) stayed at 732.02 million, with 5.88 million shares held in treasury. The total issued H shares remained at 123.12 million with no treasury shares. The public float requirement for the H shares was reported as fully compliant. The company also noted that a cumulative 5.88 million A shares remain in treasury following various repurchases from May 2024 to February 2025 and a cancellation of 3.92 million treasury shares on 29 May 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}